Balyasny Asset Management LLC Emergent Bio Solutions Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 13,286 shares of EBS stock, worth $129,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,286Holding current value
$129,139% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding EBS
# of Institutions
172Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$31.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$20.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$19.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$15 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $485M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...